vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and FIRSTSUN CAPITAL BANCORP (FSUN). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $110.0M, roughly 1.7× FIRSTSUN CAPITAL BANCORP). FIRSTSUN CAPITAL BANCORP runs the higher net margin — 19.6% vs 0.9%, a 18.7% gap on every dollar of revenue. Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 6.9%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
FirstSun Capital Bancorp is a U.S.-headquartered financial holding company that offers a comprehensive range of banking and financial services, including commercial and consumer lending, deposit products, wealth management, and treasury solutions. It mainly serves individual customers, small and medium-sized enterprises, and corporate clients across U.S. regional markets.
FOLD vs FSUN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $110.0M |
| Net Profit | $1.7M | $21.6M |
| Gross Margin | 85.7% | — |
| Operating Margin | 8.6% | — |
| Net Margin | 0.9% | 19.6% |
| Revenue YoY | 23.7% | — |
| Net Profit YoY | -88.5% | -8.4% |
| EPS (diluted) | $0.00 | $0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $110.0M | ||
| Q4 25 | $185.2M | $110.2M | ||
| Q3 25 | $169.1M | $107.3M | ||
| Q2 25 | $154.7M | $105.6M | ||
| Q1 25 | $125.2M | $96.2M | ||
| Q4 24 | $149.7M | $98.7M | ||
| Q3 24 | $141.5M | $98.2M | ||
| Q2 24 | $126.7M | $96.2M |
| Q1 26 | — | $21.6M | ||
| Q4 25 | $1.7M | $24.8M | ||
| Q3 25 | $17.3M | $23.2M | ||
| Q2 25 | $-24.4M | $26.4M | ||
| Q1 25 | $-21.7M | $23.6M | ||
| Q4 24 | $14.7M | $16.4M | ||
| Q3 24 | $-6.7M | $22.4M | ||
| Q2 24 | $-15.7M | $24.6M |
| Q1 26 | — | — | ||
| Q4 25 | 85.7% | — | ||
| Q3 25 | 88.5% | — | ||
| Q2 25 | 90.2% | — | ||
| Q1 25 | 90.7% | — | ||
| Q4 24 | 90.1% | — | ||
| Q3 24 | 90.6% | — | ||
| Q2 24 | 91.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 8.6% | 29.0% | ||
| Q3 25 | 20.3% | 26.4% | ||
| Q2 25 | -6.1% | 31.2% | ||
| Q1 25 | -6.3% | 30.9% | ||
| Q4 24 | 10.7% | 20.4% | ||
| Q3 24 | 15.3% | 29.1% | ||
| Q2 24 | 11.8% | 32.3% |
| Q1 26 | — | 19.6% | ||
| Q4 25 | 0.9% | 22.5% | ||
| Q3 25 | 10.2% | 21.6% | ||
| Q2 25 | -15.8% | 25.0% | ||
| Q1 25 | -17.3% | 24.5% | ||
| Q4 24 | 9.8% | 16.6% | ||
| Q3 24 | -4.8% | 22.8% | ||
| Q2 24 | -12.4% | 25.5% |
| Q1 26 | — | $0.76 | ||
| Q4 25 | $0.00 | $0.89 | ||
| Q3 25 | $0.06 | $0.82 | ||
| Q2 25 | $-0.08 | $0.93 | ||
| Q1 25 | $-0.07 | $0.83 | ||
| Q4 24 | $0.05 | $0.57 | ||
| Q3 24 | $-0.02 | $0.79 | ||
| Q2 24 | $-0.05 | $0.88 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $413.7M |
| Total DebtLower is stronger | $392.7M | — |
| Stockholders' EquityBook value | $274.2M | $1.2B |
| Total Assets | $949.9M | $8.6B |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $413.7M | ||
| Q4 25 | $293.5M | $652.6M | ||
| Q3 25 | $263.8M | $659.9M | ||
| Q2 25 | $231.0M | $785.1M | ||
| Q1 25 | $250.6M | $621.4M | ||
| Q4 24 | $249.9M | $615.9M | ||
| Q3 24 | $249.8M | $573.7M | ||
| Q2 24 | $260.1M | $535.8M |
| Q1 26 | — | — | ||
| Q4 25 | $392.7M | — | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | — | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $274.2M | $1.2B | ||
| Q3 25 | $230.4M | $1.1B | ||
| Q2 25 | $204.3M | $1.1B | ||
| Q1 25 | $193.6M | $1.1B | ||
| Q4 24 | $194.0M | $1.0B | ||
| Q3 24 | $178.8M | $1.0B | ||
| Q2 24 | $132.5M | $996.6M |
| Q1 26 | — | $8.6B | ||
| Q4 25 | $949.9M | $8.5B | ||
| Q3 25 | $868.8M | $8.5B | ||
| Q2 25 | $815.3M | $8.4B | ||
| Q1 25 | $789.8M | $8.2B | ||
| Q4 24 | $785.0M | $8.1B | ||
| Q3 24 | $786.6M | $8.1B | ||
| Q2 24 | $749.5M | $8.0B |
| Q1 26 | — | — | ||
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | — |
| Free Cash FlowOCF − Capex | $16.0M | — |
| FCF MarginFCF / Revenue | 8.6% | — |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | 9.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $16.3M | $111.5M | ||
| Q3 25 | $35.7M | $49.4M | ||
| Q2 25 | $-26.5M | $15.0M | ||
| Q1 25 | $7.8M | $26.4M | ||
| Q4 24 | $-3.9M | $101.1M | ||
| Q3 24 | $-23.0M | $48.1M | ||
| Q2 24 | $22.7M | $20.9M |
| Q1 26 | — | — | ||
| Q4 25 | $16.0M | $104.0M | ||
| Q3 25 | $35.3M | $47.6M | ||
| Q2 25 | $-28.9M | $13.0M | ||
| Q1 25 | $7.5M | $24.3M | ||
| Q4 24 | $-4.2M | $95.7M | ||
| Q3 24 | $-23.3M | $47.1M | ||
| Q2 24 | $21.6M | $19.9M |
| Q1 26 | — | — | ||
| Q4 25 | 8.6% | 94.3% | ||
| Q3 25 | 20.9% | 44.4% | ||
| Q2 25 | -18.7% | 12.3% | ||
| Q1 25 | 6.0% | 25.3% | ||
| Q4 24 | -2.8% | 97.0% | ||
| Q3 24 | -16.5% | 47.9% | ||
| Q2 24 | 17.0% | 20.6% |
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | 6.8% | ||
| Q3 25 | 0.2% | 1.6% | ||
| Q2 25 | 1.6% | 1.9% | ||
| Q1 25 | 0.2% | 2.1% | ||
| Q4 24 | 0.2% | 5.5% | ||
| Q3 24 | 0.3% | 1.1% | ||
| Q2 24 | 0.9% | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | 9.62× | 4.49× | ||
| Q3 25 | 2.06× | 2.13× | ||
| Q2 25 | — | 0.57× | ||
| Q1 25 | — | 1.12× | ||
| Q4 24 | -0.27× | 6.18× | ||
| Q3 24 | — | 2.15× | ||
| Q2 24 | — | 0.85× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
FSUN
| Net Interest Income | $82.8M | 75% |
| Noninterest Income | $27.2M | 25% |
